The study found that chiauranib binds to the ATP pocket of VEGFR2 and inhibits the kinase activity, and the inhibition of capillary angiogenesis coincides with the phosphorylation of VEGFR2, thereby affecting tumor angiogenesis [7]. This evidence concerns the gene KDR and neoplasm.